Coherus Oncology
CHRS
CHRS
167 hedge funds and large institutions have $1.41B invested in Coherus Oncology in 2019 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 56 increasing their positions, 43 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
14% more funds holding
Funds holding: 146 → 167 (+21)
3.11% more ownership
Funds ownership: 96.32% → 99.43% (+3.1%)
5% less capital invested
Capital invested by funds: $1.47B → $1.41B (-$67.9M)
Holders
167
Holding in Top 10
3
Calls
$15.8M
Puts
$4.99M
Top Buyers
| 1 | +$27.1M | |
| 2 | +$14.3M | |
| 3 | +$13.5M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$10.1M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$9.95M |
Top Sellers
| 1 | -$15.6M | |
| 2 | -$12M | |
| 3 | -$10.1M | |
| 4 |
HP
Hound Partners
New York
|
-$9.61M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$9.38M |